Skip to content

Video-Assisted Cordotomy Study

Video-Assisted Cordotomy Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON22264
Enrollment
15
Registered
2020-12-07
Start date
2021-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic pain in terminal cancer

Interventions

In this study a video endoscope will be added to the cordotomy in two consecutive parts. Study part A: Just like with the regular cordotomy technique a cannula will be inserted in the spinal space un

Sponsors

UMC Groningen, Dept. of Anaesthesiology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age = 18 years old ; 2. Unilateral (refractory) cancer related pain below dermatome C5; 3. Numeric Rating Scale (NRS) = 4; 4. Pharmacological therapy offers no or insufficient relief (anymore) and/or has too many side effects; 5. Life expectancy maximum 1 – 2 years; 6. Understanding of the Dutch language .

Exclusion criteria

Exclusion criteria: 1. Cordotomy in medical history; 2. Bilateral pain of equal etiology; 3. Coagulation disorder or increased bleeding tendency; 4. Increased intracranial pressure; 5. Known allergy to iodine (because contrast medium administration (Lipiodol)); 6. Unable to lie still on the operating table (~ 45-60 minutes); 7. Unable to communicate adequately during procedure; 8. Absolute contraindications MR imaging. 9. Enrolled in any other clinical study within the duration of the current study; 10. Incapable of giving consent.

Design outcomes

Primary

MeasureTime frame
Primary outcome measure will be safety measured by (S)AE, side effects and complications documentation.

Secondary

MeasureTime frame
The secondary outcomes include feasibility of the video endoscope (identification of anatomical structures and technical equipment), feasibility regarding preoperative MRI (identification of anatomical structures), effectiveness regarding pain relief (NRS and BPI), effectiveness regarding QoL (EORTC QLQ-C15-PAL, PGIC and HADS) and postoperative assessment of the thermolesion (MRI report).

Contacts

Public ContactT.F. Buisman

Universitair Medisch Centrum Groningen

t.f.buisman@umcg.nl050 3611464

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)